
| 4 min read
Quantum computing could help tackle some of drug discovery’s most difficult calculations. But better hardware, hybrid workflows, and closer collaboration with pharma will be needed to turn that potential into practical applications.
| 4 min read
A massive cancer drug deal, a new license for gut-targeted drugs, and both regulatory and company-led halts on clinical trials led the news this week.
| 4 min read
Often associated with neurodegenerative disease, amyloid fibrils may also help transport genetic material during fertilization.
| 3 min read
Developed by Inovio Pharmaceuticals, the medicine treats a rare condition caused by HPV. The approval paves the way for an era of novel DNA-based medicines.News
Cancer Research News
IVDR-certified CytoCell probes for IGH and ATM extend FISH in CLL and myeloma, filling gaps where sequencing turnaround and structural detection fall short
The multi-omics data on nearly half a million tumor cells showed that even cells with almost identical genetic makeup can show radically different behavior.
Editor's Pick
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
Explore how surface plasmon resonance can reveal binding kinetics, epitope relationships, and receptor interactions to guide antibody lead optimization.
Explore how enzymatic DNA synthesis can support longer, more complex constructs for genome editing, mRNA, and synthetic biology workflows.




















